期刊文献+

幽门螺杆菌根除疗法对胃黏膜剥离术后溃疡愈合的影响 被引量:3

Eradication of Helicobacter pylori in promotion of ulcer healing after endoscopic submucosal dissection
原文传递
导出
摘要 目的探讨根除不同菌型幽门螺杆菌(Hp)感染对胃黏膜剥离术(ESD)后溃疡愈合的疗效。方法选择2016年1月-2017年1月因胃黏膜病变接受ESD的Hp感染患者150例为研究对象,其中Ⅰ型Hp感染90例,Ⅱ型Hp感染60例,随机分为Ⅰ型Hp感染对照组和Ⅰ型Hp感染根除组,各45例,及Ⅱ型Hp感染对照组和Ⅱ型Hp感染根除组,各30例。Ⅰ型和Ⅱ型Hp感染对照组术后予埃索美拉唑;Ⅰ型和Ⅱ型Hp感染根除组在对照组基础上采取胶体果胶铋、克拉霉素、阿莫西林治疗。比较治疗后四组Hp根除率、溃疡最大径和溃疡面积及S1期溃疡愈合率。结果治疗后4周:Ⅰ型和Ⅱ型Hp感染根除组患者Hp根除率分别为91.11%(41/45)和93.33%(28/30)高于Ⅰ型和Ⅱ型Hp感染对照组0%(P<0.001);治疗后8周:Ⅰ型和Ⅱ型Hp感染根除组患者的溃疡最大径和溃疡面积分别为(3.07±0.45)mm、(2.19±0.41)mm和(77.40±8.55)mm^2、(76.57±8.43)mm^2低于Ⅰ型和Ⅱ型Hp感染对照组(P<0.001);Ⅱ型Hp感染对照组患者的溃疡最大径和溃疡面积分别为(6.12±0.67)mm和(143.21±15.45)mm^2低于Ⅰ型Hp感染对照组(P<0.001);Ⅰ型和Ⅱ型Hp感染根除组患者的S1期溃疡愈合率分别为84.44%(38/45)和86.67%(26/30)均高于Ⅰ型和Ⅱ型Hp感染对照组(P<0.05);Ⅱ型Hp感染对照组患者的S1期溃疡愈合率为60.00%(18/30)高于Ⅰ型Hp感染对照组(P=0.023)。结论根除Ⅰ型和Ⅱ型Hp感染均可促进ESD术后患者溃疡愈合,尤其对Ⅰ型Hp感染,均具有一定的临床意义。 OBJECTIVE To explore the eradication of different species of Helicobacter pylori(Hp)infection in promotion of ulcer healing after endoscopic submucosal dissection(ESD).METHODS A total of 150 patients with Hp infection who received ESD for treatment of gastric mucosal lesion from Jan 2016 to Jan 2017 were recruited as the study objects,including 90 cases of typeⅠ Hp infection and 60 cases of typeⅡ Hp infection.The 150 patients who received ESD were randomly divided into the typeⅠ Hp infection control group with 45 cases,typeⅠ Hp infection eradication group with 45 cases,typeⅡ Hp infection control group with 30 cases and typeⅡ Hp infection eradication group with 30 cases.The type Ⅰ and Ⅱ Hp infection control group were treated with esomeprazole after the ESD,while the typeⅠ andⅡ Hp infection eradication group were treated with additional colloidal bismuth pectin,clarithromycin and amoxicillin on basis of the treatment of the control group.The eradication rate of Hp,maximum diameter of ulcer,area of ulcer and healing rate of ulcer in S1 were observed and compared among the four groups after the treatment.RESULTS The eradication rates of Hp of the typeⅠ andⅡ Hp infection eradication group were respectively 91.11%(41/45)and 93.33%(28/30)after the treatment for 4 weeks,significantly higher than those of the typeⅠ and Ⅱ Hp infection control group(P〈0.001).The maximum diameter and area of ulcer of the type Ⅰ and Ⅱ Hp infection eradication groups were respectively(3.07±0.45)mm,(2.19±0.41)mm and(77.40±8.55)mm^2 and(76.57±8.43)mm^2 after the treatment for 8 weeks,lower than those of the typeⅠandⅡ Hp infection control groups.The maximum diameter and area of ulcer of the typeⅡ Hp infection control group were respectively(6.12±0.67)mm and(143.21±15.45)mm^2,significantly less than those of the typeⅠ Hp infection control group(P〈0.001).The healing rates of S1 ulcer of the typeⅠ andⅡ Hp infection eradication group were respectively 84.44%(38/45)and 86.67%(26/30),significantly higher than those of the typeⅠ andⅡ Hp infection control group(P〈0.05).The healing rate of S1 ulcer of the typeⅡ Hp infection control group was 60.00%(18/30),significantly higher than that of the type Ⅰ Hp infection control group(P=0.032).CONCLUSION The eradication of the typeⅠ andⅡ Hp infection may promote the healing of ulcer after the ESD,especially the typeⅠ Hp infection,which has certain clinical significance.
作者 杨迪 卢光荣 林李淼 YANG Di;LU Guang-rong;LIN Li-miao(Yongjia County Hospital of Traditional Chinese Medicine,Wenzhou,Zhejiang 325102,China)
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2018年第20期3072-3075,共4页 Chinese Journal of Nosocomiology
基金 浙江省医学会临床科研A类基金资助项目(2016ZYC-A34)
关键词 菌型 幽门螺杆菌 胃黏膜剥离术 溃疡愈合 Specie Helicobacter pylori Endoscopic submucosal dissection Healing of ulcer
  • 相关文献

参考文献7

二级参考文献45

  • 1Tomohiko Richard Ohya,Hiroki Endo,Kei Kawagoe,Tatsuro Yanagawa,Katsuhiro Hanawa,Ken Ohata,Masako Asayama,Kantaro Hisatomi,Takuma Teratani,Toshiaki Gunji,Hajime Sato,Nobuyuki Matsuhashi.A prospective randomized trial of lafutidine vs rabeprazole on post-ESD gastric ulcers[J].World Journal of Gastrointestinal Endoscopy,2010,2(1):36-40. 被引量:7
  • 2Masaki Takayama,Shigenaga Matsui,Masanori Kawasaki,Yutaka Asakuma,Toshiharu Sakurai,Hiroshi Kashida,Masatoshi Kudo.Efficacy of treatment with rebamipide for endoscopic submucosal dissection-induced ulcers[J].World Journal of Gastroenterology,2013,19(34):5706-5712. 被引量:15
  • 3窦艳,王向东,梁浩,刘生杰,董圣会,王瑾.荆花胃康胶丸治疗幽门螺杆菌相关性消化性溃疡的疗效和安全性[J].中国新药杂志,2004,13(7):650-652. 被引量:18
  • 4张万岱,陈治水,危北海,李道本.消化性溃疡的中西医结合诊治方案(草案)[J].中国中西医结合消化杂志,2005,13(2):136-138. 被引量:81
  • 5Zojaji H,Talaie R,Mirsattari D. The efficacy of Helico-bacter pylori eradication regimen with and without vitamin Csupplementation[J].{H}Digestive and Liver Disease,2009,(9):644-647.
  • 6Eisig J N,Silva FM,Barbuti RC. Efficacy of a 7-day course of furazolidone,levofloxacin,and lansoprazole after failedHelicobacter pylori eradication[J].{H}BMC Gastroenterology,2009.38.
  • 7Sezikli M,Cetinkaya ZA,Sezikli H. Oxidative stress in Helicobacter pylori infection:does supplementation with vitamins C and Eincrease the eradication rate[J].{H}HELICOBACTER,2009,(4):280-285.
  • 8Fuccio L,Eusebi LH,Zagari RM. Helicobacter pylori eradication treatment reduces but does not abolish the risk of gastric cancer[J].{H}American Journal of Gastroenterology,2009,(12):3100,3101-3102.
  • 9Kim BG,Lee DH,Ye BD. Comparison of 7-day and 14-day proton pump inhibitor-containing triple therapy forHelicobacter pylori eradication:neither treatment duration provides acceptable eradication ratein Korea[J].{H}HELICOBACTER,2007,(1):31-35.
  • 10Zhang Geng,Zhang Chun-dong. Effect of a Chinese method on 100 patients with peptic ulcer[J].Hebei journal of Traditional Chinese Medicine,2011,(2):203-204.

共引文献385

同被引文献29

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部